Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation

In inflammatory diseases occurring outside the CNS, communication between the periphery and the brain via humoral and/or neural routes results in central neural changes and associated behavioral alterations. We have recently identified another immune-to-CNS communication pathway in the setting of organ-centered peripheral inflammation: namely, the entrance of immune cells into the brain. In our current study, using a mouse model of inflammatory liver injury, we have confirmed the significant infiltration of activated monocytes into the brain in mice with hepatic inflammation and have defined the mechanism that mediates this trafficking of monocytes. Specifically, we show that in the presence of hepatic inflammation, mice demonstrate elevated cerebral monocyte chemoattractant protein (MCP)-1 levels, as well as increased numbers of circulating CCR2-expressing monocytes. Cerebral recruitment of monocytes was abolished in inflamed mice that lacked MCP-1/CCL2 or CCR2. Furthermore, in mice with hepatic inflammation, microglia were activated and produced MCP-1/CCL2 before cerebral monocyte infiltration. Moreover, peripheral tumor necrosis factor (TNF)α signaling was required to stimulate microglia to produce MCP-1/CCL2. TNFα signaling via TNF receptor 1 (TNFR1) is required for these observed effects since in TNFR1 deficient mice with hepatic inflammation, microglial expression of MCP-1/CCL2 and cerebral monocyte recruitment were both markedly inhibited, whereas there was no inhibition in TNFR2 deficient mice. Our results identify the existence of a novel immune-to-CNS communication pathway occurring in the setting of peripheral organ-centered inflammation which may have specific implications for the development of alterations in cerebral neurotransmission commonly encountered in numerous inflammatory diseases occurring outside the CNS.

[1]  N. Van Rooijen,et al.  Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis , 2008, The Journal of experimental medicine.

[2]  R. Dantzer,et al.  Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase , 2008, Psychopharmacology.

[3]  S. Rivest,et al.  MyD88 signaling in brain endothelial cells is essential for the neuronal activity and glucocorticoid release during systemic inflammation , 2008, Molecular Psychiatry.

[4]  E. Masliah,et al.  Neurobiology of HIV , 2008, International review of psychiatry.

[5]  A. Mildner,et al.  Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions , 2007, Nature Neuroscience.

[6]  W. Rostène,et al.  Chemokines: a new class of neuromodulator? , 2007, Nature Reviews Neuroscience.

[7]  R. Dantzer,et al.  TNFα-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I , 2007, Journal of Neuroimmunology.

[8]  D. Dickson,et al.  Actin-binding Proteins Coronin-1a and IBA-1 are Effective Microglial Markers for Immunohistochemistry , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  C. Zwingmann,et al.  Endotoxemia produces coma and brain swelling in bile duct ligated rats , 2007, Hepatology.

[10]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[11]  M. Odeh Pathogenesis of hepatic encephalopathy: the tumour necrosis factor‐α theory , 2007, European journal of clinical investigation.

[12]  J. O'Callaghan,et al.  Divergent Roles for Tumor Necrosis Factor-α in the Brain , 2007, Journal of Neuroimmune Pharmacology.

[13]  S. Hopkins Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration. , 2007, Acta bio-medica : Atenei Parmensis.

[14]  S. Rivest,et al.  Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system , 2007, Brain, Behavior, and Immunity.

[15]  F. Tacke,et al.  Migratory fate and differentiation of blood monocyte subsets. , 2006, Immunobiology.

[16]  V. Pérez-Alvarez,et al.  Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[17]  S. Gold,et al.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. , 2006, Neurologic clinics.

[18]  R. Dantzer Cytokine, sickness behavior, and depression. , 2006, Neurologic clinics.

[19]  Thomas Christen,et al.  Connexin37 protects against atherosclerosis by regulating monocyte adhesion , 2006, Nature Medicine.

[20]  M-A Mayoux-Benhamou Fatigue and rheumatoid arthritis. , 2006, Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique.

[21]  R. Duman,et al.  TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting , 2006, Biological Psychiatry.

[22]  R. Klein,et al.  A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. , 2006, The American journal of pathology.

[23]  T. Möller,et al.  Microglia Biology in Health and Disease , 2006, Journal of Neuroimmune Pharmacology.

[24]  M. Swain Fatigue in liver disease: pathophysiology and clinical management. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[25]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[26]  A. Gottlieb,et al.  Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial , 2006, The Lancet.

[27]  P. Kubes,et al.  TNF‐α–secreting monocytes are recruited into the brain of cholestatic mice , 2006 .

[28]  S. Gold,et al.  Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[30]  R. Dantzer,et al.  Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. A. Romanovsky,et al.  Fever and hypothermia in systemic inflammation: recent discoveries and revisions. , 2005, Frontiers in bioscience : a journal and virtual library.

[32]  Ansuman T. Satpathy,et al.  IL-1β-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes1 , 2005, The Journal of Immunology.

[33]  S. Sarin,et al.  Beneficial Effects of Tumor Necrosis Factor-α Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis , 2004, American Journal of Gastroenterology.

[34]  Shigeo Kobayashi,et al.  Signaling the brain in inflammation: the role of endothelial cells. , 2004, Frontiers in bioscience : a journal and virtual library.

[35]  A. Masuda,et al.  Kupffer cell–derived interleukin 10 is responsible for impaired bacterial clearance in bile duct–ligated mice , 2004, Hepatology.

[36]  P. Lipsky,et al.  Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. , 2004, Arthritis and rheumatism.

[37]  S. Cepok,et al.  Multiple sclerosis -- a coordinated immune attack across the blood brain barrier. , 2004, Current neurovascular research.

[38]  S. Kunkel,et al.  Alterations in cytokine/chemokine expression during organ-to-organ communication established via acetaminophen-induced toxicity. , 2003, Experimental and molecular pathology.

[39]  B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[40]  G. Davies-Jones,et al.  Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells , 2003, Journal of Neuroimmunology.

[41]  W. Kuziel,et al.  Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS , 2003, The Journal of Neuroscience.

[42]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[43]  Y. Pollak,et al.  The EAE-associated behavioral syndrome I. Temporal correlation with inflammatory mediators , 2003, Journal of Neuroimmunology.

[44]  Y. Pollak,et al.  The EAE-associated behavioral syndrome II. Modulation by anti-inflammatory treatments , 2003, Journal of Neuroimmunology.

[45]  R. Ransohoff,et al.  The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). , 2003, Seminars in immunology.

[46]  D. Gouma,et al.  Endogenous interferon γ protects against cholestatic liver injury in mice , 2002 .

[47]  B. Rovin,et al.  HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Bala,et al.  Infliximab Improves Quality of Life in Patients with Crohn's Disease , 2002, Inflammatory bowel diseases.

[49]  R. Tandon,et al.  Fatigue in cholestatic liver disease—a perplexing symptom , 2002, Postgraduate medical journal.

[50]  W. Rostène,et al.  Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain , 2002, Journal of neurochemistry.

[51]  M. Swain,et al.  Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. , 2002, Gastroenterology.

[52]  G. Tarozzo,et al.  Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain , 2002, Stroke.

[53]  J. Clements,et al.  Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. , 2001, The Journal of infectious diseases.

[54]  L. Koniaris,et al.  Cytokine-Responsive Gene-2/IFN-Inducible Protein-10 Expression in Multiple Models of Liver and Bile Duct Injury Suggests a Role in Tissue Regeneration1 , 2001, The Journal of Immunology.

[55]  S. Rivest,et al.  Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP‐1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines , 2001, The Journal of comparative neurology.

[56]  B. Rollins,et al.  Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.

[57]  M. Swain,et al.  Increased midbrain 5-HT1A receptor number and responsiveness in cholestatic rats , 2001, Brain Research.

[58]  R. Dantzer,et al.  Role of interleukin‐1β and tumour necrosis factor‐α in lipopolysaccharide‐induced sickness behaviour: a study with interleukin‐1 type I receptor‐deficient mice , 2000 .

[59]  H. Weiner,et al.  Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.

[60]  K. Frei,et al.  TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. , 2000, Brain : a journal of neurology.

[61]  A. Kilbourne,et al.  The impact of irritable bowel syndrome on health-related quality of life. , 2000, Gastroenterology.

[62]  Q. Pittman,et al.  Attenuated febrile response to lipopolysaccharide in rats with biliary obstruction. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[63]  R. Dantzer,et al.  Increased Sensitivity of Prediabetic Nonobese Diabetic Mouse to the Behavioral Effects of IL-1 , 1999, Brain, Behavior, and Immunity.

[64]  S. Rivest,et al.  Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood–brain barrier , 1999, Neuroscience.

[65]  H. Anisman,et al.  Sensitization to the Effects of Tumor Necrosis Factor-α: Neuroendocrine, Central Monoamine, and Behavioral Variations , 1999, The Journal of Neuroscience.

[66]  K. Rioux,et al.  Augmented interleukin‐1β–induced depression of locomotor activity in cholestatic rats , 1998, Hepatology.

[67]  M. Swain,et al.  Chronic cholestasis in rats induces anhedonia and a loss of social interest , 1998, Hepatology.

[68]  M. Swain,et al.  Improvement in cholestasis‐associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment , 1997, Hepatology.

[69]  M. Burdick,et al.  Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. , 1996, Journal of immunology.

[70]  D. Gouma,et al.  Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. , 1996, Gut.

[71]  M. Swain,et al.  Defective corticotropin‐releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: Implications for cholestatic liver disease–related sickness behaviors , 1995, Hepatology.

[72]  M. Swain,et al.  Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. , 1993, The Journal of clinical investigation.

[73]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[74]  ScienceDirect Annales de réadaptation et de médecine physique , 2008 .

[75]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[76]  R. Ransohoff,et al.  The expression and function of chemokines involved in CNS inflammation. , 2006, Trends in pharmacological sciences.

[77]  B. Barna,et al.  Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression. , 2005, Clinical immunology.

[78]  T. Kielian Microglia and chemokines in infectious diseases of the nervous system: views and reviews. , 2004, Frontiers in bioscience : a journal and virtual library.